acetyl l carnitine for frontal temporal dementia Frontiers Uncovering pathophysiological changes in frontotemporal
Description
10.1016/j.susmat.2023.e00809 175 ShahbazM.AkramA.RajaN
Solubility and formulation compatibility are other vital aspects when comparing acetyl-L-carnitine vs L-carnitine tartrate
8ln, pyridoxine treatment slightly increased the DOPAC level but did not alter the dopamine and GABA levels, indicating that supplementation with pyridoxine has few effects on dopamine and GABA levels under physiological conditions
can be highly beneficial
